Paper30621069
The Role of Lipids in Parkinson's Disease.
Xicoy H and 2 others. Cells, 2019. Cited by 204 papers, by iCite.
Cite this record
ConductScience Library. The Role of Lipids in Parkinson's Disease. Papers, record 30621069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30621069
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lipid Metabolism | Major topic |
| Parkinson Disease | Major topic |
| Animals | |
| Cells, Cultured | |
| Disease Models, Animal | |
| Dopaminergic Neurons | |
| Female | |
| Humans | |
| Male |
Source PubMed
References577
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26783361 | Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism. | J Lipid Res | 2016 | https://conductscience.org/library/papers/26783361 | PubMed |
| 2 | 23303906 | Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis. | Physiol Rev | 2013 | https://conductscience.org/library/papers/23303906 | PubMed |
| 3 | 21942574 | Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. | Chem Rev | 2011 | https://conductscience.org/library/papers/21942574 | PubMed |
| 4 | 21330368 | Specificity and kinetics of alpha-synuclein binding to model membranes determined with fluorescent excited state intramolecular proton transfer (ESIPT) probe. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21330368 | PubMed |
| 5 | 24035896 | Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. | Neurosci Lett | 2013 | https://conductscience.org/library/papers/24035896 | PubMed |
| 6 | 9633704 | Parkinson's disease: improved function with GM1 ganglioside treatment in a randomized placebo-controlled study. | Neurology | 1998 | https://conductscience.org/library/papers/9633704 | PubMed |
| 7 | 27059734 | Major apoptotic mechanisms and genes involved in apoptosis. | Tumour Biol | 2016 | https://conductscience.org/library/papers/27059734 | PubMed |
| 8 | 25790164 | Molecular details of α-synuclein membrane association revealed by neutrons and photons. | J Phys Chem B | 2015 | https://conductscience.org/library/papers/25790164 | PubMed |
| 9 | 24883315 | Fatty acids in energy metabolism of the central nervous system. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/24883315 | PubMed |
| 10 | 26498506 | Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice. | Neuropharmacology | 2016 | https://conductscience.org/library/papers/26498506 | PubMed |
| 11 | 29735655 | Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/29735655 | PubMed |
| 12 | 28649614 | Integrated molecular landscape of Parkinson's disease. | NPJ Parkinsons Dis | 2017 | https://conductscience.org/library/papers/28649614 | PubMed |
| 13 | 23939407 | Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression. | J Parkinsons Dis | 2012 | https://conductscience.org/library/papers/23939407 | PubMed |
| 14 | 18597941 | Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress. | Neurosci Lett | 2008 | https://conductscience.org/library/papers/18597941 | PubMed |
| 15 | 26331605 | Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition. | Cell Metab | 2015 | https://conductscience.org/library/papers/26331605 | PubMed |
| 16 | 23618683 | GAK rs1564282 and DGKQ rs11248060 increase the risk for Parkinson's disease in a Chinese population. | J Clin Neurosci | 2013 | https://conductscience.org/library/papers/23618683 | PubMed |
| 17 | 23040807 | Endocannabinoid signaling and synaptic function. | Neuron | 2012 | https://conductscience.org/library/papers/23040807 | PubMed |
| 18 | 27527987 | Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis. | Pharmacoepidemiol Drug Saf | 2017 | https://conductscience.org/library/papers/27527987 | PubMed |
| 19 | 17449457 | The 6-hydroxydopamine model of Parkinson's disease. | Neurotox Res | 2007 | https://conductscience.org/library/papers/17449457 | PubMed |
| 20 | 25852197 | Lysophosphatidic acid signalling in development. | Development | 2015 | https://conductscience.org/library/papers/25852197 | PubMed |
Cited by145
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 204 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42980051 | Integrative Transcriptomic and Network Analyses Reveal Common Molecular Signatures and Turmeric-Derived Common Therapeutic Candidates for Neurological Diseases. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42980051 | PubMed |
| 42813030 | Unlocking Parkinson's disease: harnessing the untapped potential of fatty acid metabolism in disease pathogenesis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42813030 | PubMed |
| 42645231 | Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson's Disease. | Cells | 2026 | https://conductscience.org/library/papers/42645231 | PubMed |
| 42450338 | Rewiring Lipid Metabolism: PINK1 as a Central Regulator of Mitochondrial Homeostasis in Parkinson's Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450338 | PubMed |
| 42359371 | Integration of the serum metabolome and gut microbiome underscores the importance of altered lipid metabolism and potential immune modulation in Parkinson's Disease. | Brain Disord | 2026 | https://conductscience.org/library/papers/42359371 | PubMed |
| 42329290 | Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in rats. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42329290 | PubMed |
| 42168845 | Integrative multi-omics analysis reveals host-microbiome metabolic alterations and candidate biomarkers in Parkinson's disease. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42168845 | PubMed |
| 42154358 | Nutritional Perspectives on Parkinson's Disease: The Potential Neuroprotective Role of Coconut Derived Supplements. | Curr Nutr Rep | 2026 | https://conductscience.org/library/papers/42154358 | PubMed |
| 42021550 | Acupuncture: A Promising Non-Pharmacological Approach to Parkinson's Disease Management. | Brain Behav | 2026 | https://conductscience.org/library/papers/42021550 | PubMed |
| 42018128 | The Emerging Parkinson's Disease Oxylipin-Ome. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42018128 | PubMed |
| 42014729 | Personalized metabolite biomarker predictions reveal heterogeneous characteristics of Parkinson's disease. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/42014729 | PubMed |
| 41704776 | From lipid function to dysfunction: Very long-chain fatty acids as emerging regulators of neuroinflammatory pathways. | iScience | 2026 | https://conductscience.org/library/papers/41704776 | PubMed |
| 41696714 | The Nodding syndrome cerebrospinal fluid proteome: a lens into neurodevelopmental failure consistent with environmentally triggered MECP2 dysregulation? | Front Mol Neurosci | 2026 | https://conductscience.org/library/papers/41696714 | PubMed |
| 41594727 | Synaptic Vesicle Disruption in Parkinson's Disease: Dual Roles of α-Synuclein and Emerging Therapeutic Targets. | Brain Sci | 2025 | https://conductscience.org/library/papers/41594727 | PubMed |
| 41574983 | Exploring the Fecal Microbiome Dysbiosis and Its Plasma Metabolome Determinants in Advanced Parkinson's Disease With Motor Complications. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/41574983 | PubMed |
| 41519835 | Metabolomic breath landscape analysis unravels lipid biomarker candidates in patients with genetic and idiopathic Parkinson's disease. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/41519835 | PubMed |
| 41510100 | Development of a fatty acid metabolism (FAM)-related gene signature for prognosis prediction and personalized therapy in lower grade gliomas. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/41510100 | PubMed |
| 41482272 | Multiomic Analysis Reveals Molecular Pathways Associated with Intestinal Aggregation of α-Synuclein. | ACS Chem Biol | 2026 | https://conductscience.org/library/papers/41482272 | PubMed |
| 41381460 | Metabolomic profiles of depression in Parkinson's disease patients. | NPJ Parkinsons Dis | 2025 | https://conductscience.org/library/papers/41381460 | PubMed |
| 41299626 | Exploring the skin as an open window onto neurodegenerative diseases. | Transl Neurodegener | 2025 | https://conductscience.org/library/papers/41299626 | PubMed |
Genes68
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30621069
GET https://conductscience.org/api/papers/v1/30621069/references?page=2